Review: Varenicline for tobacco cessation does not increase CV serious adverse events

Annals of Internal Medicine

Volumn 157, Issue 4, 2012, Pages

  Prochaska, J J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VARENICLINE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MEDLINE; MONOTHERAPY; NOTE; PRIORITY JOURNAL; RISK REDUCTION; SIDE EFFECT; SMOKING CESSATION; SUDDEN DEATH; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 84865650252     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: None     Document Type: Note

References (0)